Related Experiment Video
Updated: Jul 9, 2026

Cell Aggregation Assays to Evaluate the Binding of the Drosophila Notch with Trans-Ligands and its Inhibition by Cis-Ligands
Published on: January 2, 2018
Delta-like 4/Notch signaling and its therapeutic implications
1Tumor Biology and Angiogenesis, Genentech, Inc., South San Francisco, CA 94080, USA. minhong@gene.com
Targeting Delta-like 4 (Dll4)-mediated Notch signaling, a key pathway in angiogenesis, shows promise for cancer therapy. Blocking Dll4/Notch signaling inhibits tumor growth by creating defective vasculature, offering a new strategy against treatment resistance.
Area of Science:
- Molecular biology
- Cancer research
- Vascular biology
Background:
- Angiogenesis, the formation of new blood vessels, is crucial for tumor growth and a target for cancer therapies.
- Vascular endothelial growth factor (VEGF) signaling is a validated target, with bevacizumab approved for certain cancers.
- Delta-like 4 (Dll4)-mediated Notch signaling is another critical pathway in vascular development and angiogenesis.
Purpose of the Study:
- To explore the role of Dll4-mediated Notch signaling in angiogenesis and its potential as a cancer therapy target.
- To understand the consequences of Dll4/Notch signaling attenuation on tumor vasculature and growth.
Main Methods:
- Review of recent studies on Dll4 function in angiogenesis.
- Analysis of preclinical data on the effects of Dll4/Notch signaling blockade.
Main Results:
- Dll4 acts downstream of VEGF, providing negative feedback on VEGF signaling.
- Attenuation of Dll4/Notch signaling leads to chaotic vascular networks with excessive sprouting.
- Blocking Dll4/Notch signaling paradoxically increases tumor vessel density but inhibits tumor growth due to defective vasculature.
Conclusions:
- Dll4/Notch signaling blockade is a promising strategy for antiangiogenesis cancer therapy.
- This approach may be particularly effective in overcoming resistance to existing therapies.
Related Concept Videos
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Signal Transduction: Overview
Typically, signal transduction involves three...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Hedgehog Signaling Pathway
